Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ...

Increase awareness about colorectal cancer to promote early diagnosis and treatment, reducing mortality rates worldwide.

Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...

A recent study found that 80% of Indian IT professionals have fatty liver due to a sedentary lifestyle, poor diet, and work ...

Type 1, not type 2 diabetes, is autoimmune. There are other rarer autoimmune types. Learn about type 2 diabetes, immunity, ...

Ty reminds employers that under the Americans with Disabilities Act, dementia is considered a disability and is protected ...

Researchers from the Keck School of Medicine of USC have found that persistent organic pollutants (POPs)—synthetic toxic ...

March is Colon Cancer Awareness Month. Colon cancer is the second leading cause of cancer deaths in the United States. "We ...

According to the Association’s 2025 Statistics Update: ...

Risk factors are things that change our likelihood of developing ... aims to help you understand more about vascular dementia. It gives an overview of the causes, symptoms and treatments. Alzheimer’s ...

While there is no sure-fire way to prevent mild cognitive impairment, there are steps we can take to look after our brain health that may also help to reduce our risk. While there is no sure-fire way ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...